Macrophage migration inhibitory factor activates the inflammatory response in joint capsule fibroblasts following

Yuxin Zhang1,2, Shenji Lu1, Shuai Fan1

  • 1Department of Rehabilitation Medicine, Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200011, China.

Aging
|February 18, 2021
PubMed
Abstract

Insights

Macrophage migration inhibitory factor (MIF) drives joint capsule fibrosis and inflammation in post-traumatic joint contracture (PTJC). Targeting the MIF/CD74 pathway offers a promising therapeutic strategy for PTJC.

Area of Science:

  • Biomedical Science
  • Cell Biology
  • Pathophysiology

Background:

  • Post-traumatic joint contracture (PTJC) involves joint capsule fibrosis driven by inflammation.
  • Fibroblasts and proinflammatory cytokines are key players in PTJC pathogenesis.
  • Macrophage migration inhibitory factor (MIF) is a significant proinflammatory cytokine implicated in fibrosis.

Purpose of the Study:

  • To investigate the role of MIF in the development of PTJC.
  • To elucidate the mechanisms by which MIF influences joint capsule fibroblasts (JFs).
  • To identify potential therapeutic targets for PTJC.

Main Methods:

  • Utilized a rat PTJC model and a fibroblast inflammation model.
  • Assessed MIF expression and its effects on JF proliferation, migration, and cytokine production.
  • Employed qRT-PCR, western blot, immunoprecipitation, and transcriptome analysis to explore molecular mechanisms.

Main Results:

  • MIF levels were elevated in the joint capsule post-PTJC and localized with fibroblasts.
  • MIF inhibition significantly reduced joint capsule inflammation and fibrosis.
  • MIF promoted JF proliferation and migration via the MIF/CD74-mediated MAPK/NF-κB pathway, influencing lipid metabolism genes.

Conclusions:

  • The MIF/CD74 axis is crucial for JF inflammation in PTJC.
  • Targeting the MIF/CD74 pathway presents a potential therapeutic avenue for joint capsule fibrosis.

Related Concept Videos

Inflammatory Response II: Inflammatory Exudate and Tissue Repair01:24

Inflammatory Response II: Inflammatory Exudate and Tissue Repair

The immune system's inflammatory response destroys the invading pathogen, permitting the tissue to heal. The changes during the cellular and vascular stages allow exudate formation at the site of inflammation. The inflammatory exudate released from the wound has high protein content and a specific gravity above 1.020.
The typical wound exudate is odorless, transparent, straw-colored, thin, and watery. Exudate, however, can differ depending on the state of wound healing. Likewise, the...
6.5K
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
15.0K
Inflammation01:38

Inflammation

Overview
57.6K
Inflammatory Response I: Vascular and Cellular01:30

Inflammatory Response I: Vascular and Cellular

The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...
14.1K